The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Actionability of comprehensive genomic profiling compared to the tissue-based and plasma-based assay in patients with metastatic breast cancer: A real-world study.
 
Hiroshi Tada
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Kyowa Kirin International; Lilly Japan; MSD; Novartis; Pfizer; Takeda
 
Jun Yasuda
No Relationships to Disclose
 
Hidekazu Shirota
No Relationships to Disclose
 
Minoru Miyashita
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Lilly O.; MSD; Pfizer; Taiho Oncology
 
Narumi Harada-shoji
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Kyowa Kirin; Lilly O.; Novartis; Pfizer; Takeda
 
Yohei Hamanaka
No Relationships to Disclose
 
Akiko Ebata
Speakers' Bureau - Kyowa Kirin
 
Miku Sato
Speakers' Bureau - Chugai Pharma; Lilly Japan
 
Takanori Ishida
Speakers' Bureau - Lilly O.; Pfizer; Roche